Interestingly, it is worth noting that GPR87 is generally considered as a tumor driver in the tumorigenesis of pancreatic cancer (45), lung cancer (46), bladder cancer (47), and liver cancer (48). Here, GPR87 is linked to urinary bladder carcinoma.